Use the Back button in your browser to see the other results of your search or to select another record.
| Role of the physiotherapist in the initial management of osteoarthritis in primary care |
| Cobo AG, Fiallos DLJ, Pazmino DIS |
| NeuroQuantology 2022;20(13):2095-2101 |
| clinical trial |
| 4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: No. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
|
INTRODUCTION: Early access to a physical therapist is safe and effective for patients with musculoskeletal disorders. OBJECTIVE: To examine the differences in HRQOL for patients with OA with TF assessment versus medical assessment in primary care. METHODS: A pragmatic, randomized, multicenter, pragmatic, controlled study comparing treatment by a physical therapist or a primary care physician was conducted. RESULTS: HRQoL improved 12 months after evaluation for all patients ("Time" variable: EQ-5D-3L index, p < 0.001; EQ-5D-3L VAS, p = 0.0049). CONCLUSIONS: The study found no differences in HRQOL, adjusted for pain and physical function, when the care process was initiated by TF versus physician assessment.
|